Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 19, 2022 (4 years ago)

Prednisone Tablets USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

Affected NDC 64380-0785-06

Compare with the code on your package — it is the most precise check available.

Drug: Prednisone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
prednisone
NDC 64380-0785
20 mg/1 Tablet
Oral
Strides Pharma Science Limited Rx
Recalling firm
Strides Pharma Inc.
NDC code
64380-785-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1330-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Prednisone recalls

See all
Class II · Moderate risk

PredniSONE Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0193-2024
Class II · Moderate risk

Prednisone Tablets

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Terminated Labeling / mix-up Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class II · Moderate risk

PredniSONE Tablets USP

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Terminated Failed specification West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class III · Low risk

Prednisone 20 mg

Labeling: Not elsewhere classified. NDC number is incorrect on the container.

Terminated Labeling / mix-up Northwind Pharmaceuticals LLC NDC 51655-320-53 D-0485-2016
Class II · Moderate risk

Prednisone active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-858-2015

Other recalls by Strides Pharma Inc.

All 2022 recalls